104 related articles for article (PubMed ID: 101014)
21. Heteroantisera against a blast cell antigen.
Billing R; Terasaki PI; Clark B
Clin Immunol Immunopathol; 1979 Aug; 13(4):435-43. PubMed ID: 90573
[No Abstract] [Full Text] [Related]
22. Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases.
Janossy G; Hoffbrand AV; Greaves MF; Ganeshaguru K; Pain C; Bradstock KF; Prentice HG; Kay HE; Lister TA
Br J Haematol; 1980 Feb; 44(2):221-34. PubMed ID: 6990961
[TBL] [Abstract][Full Text] [Related]
23. Differentiation patterns in the blastic phase of chronic myeloid leukemia.
Griffin JD; Todd RF; Ritz J; Nadler LM; Canellos GP; Rosenthal D; Gallivan M; Beveridge RP; Weinstein H; Karp D; Schlossman SF
Blood; 1983 Jan; 61(1):85-91. PubMed ID: 6571717
[TBL] [Abstract][Full Text] [Related]
24. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
[TBL] [Abstract][Full Text] [Related]
25. [Philadelphia chromosome-positive chronic myeloid leukemia with washing out of Ph'-negative lymphoid blasts and with meningiosis: atypical blast crisis or a 2d leukemia?].
Merlin D; Auf der Maur P; Kappeler R
Schweiz Med Wochenschr; 1984 Mar; 114(9):303-8. PubMed ID: 6584970
[TBL] [Abstract][Full Text] [Related]
26. Human leukaemia-associated antigens expressed by acute lymphocytic leukaemias and their detection with heterologous antisera to T, B-, and non-T-non-B subtype AL blasts.
Thränhardt H; Milleck J; Zintl F; Plenert W; Koppitz D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):321-40. PubMed ID: 89983
[TBL] [Abstract][Full Text] [Related]
27. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies reactive with human myeloid leukaemia cells.
Ball ED; Fanger MW
Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
[TBL] [Abstract][Full Text] [Related]
30. Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia.
Janossy G; Roberts M; Greaves MF
Lancet; 1976 Nov; 2(7994):1058-61. PubMed ID: 62904
[TBL] [Abstract][Full Text] [Related]
31. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
[TBL] [Abstract][Full Text] [Related]
32. Emergence of a hybrid surface phenotype in mixed blast crisis of chronic granulocytic leukaemia.
Hagner G; Kölmel HW; Wirthmüller R
Acta Haematol; 1983; 70(5):325-9. PubMed ID: 6414227
[TBL] [Abstract][Full Text] [Related]
33. Maturation of B-lineage blast crisis cells in chronic myeloid leukemia.
Ng CS; Chan JK; Arnold M
Am J Hematol; 1987 Jun; 25(2):231-3. PubMed ID: 3111248
[TBL] [Abstract][Full Text] [Related]
34. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu
Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630
[TBL] [Abstract][Full Text] [Related]
35. [A case of blast crisis of chronic myelogenous leukemia with lymphoid blasts possessing B-cell markers (author's transl)].
Ohno R; Ueda R; Suzuki H; Tanaka M; Ezaki K; Kawashima K; Yamada K; Yoshikawa H; Shamoto M; Kawabe M
Rinsho Ketsueki; 1978 Feb; 19(2):166-71. PubMed ID: 306451
[No Abstract] [Full Text] [Related]
36. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
[TBL] [Abstract][Full Text] [Related]
37. Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage.
Iizasa T; Yamaguchi Y; Tagawa M; Fujisawa T; Saito H; Kondo H; Matsuo Y; Minowada J; Taniguchi M
Jpn J Cancer Res; 1991 Feb; 82(2):213-8. PubMed ID: 1900825
[TBL] [Abstract][Full Text] [Related]
38. [Childhood chronic myelogenous leukemia with blastic crisis showing pre-B cell and myelocytic phenotypes].
Nakadate H; Kobayashi R; Yanazume M; Nishi M; Hattori T; Hatae Y; Takeda T
Rinsho Ketsueki; 1987 Jan; 28(1):76-80. PubMed ID: 3494864
[No Abstract] [Full Text] [Related]
39. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
40. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
